The Secret Agents behind Q
Why we are named MI7
During the first world war British Intelligence created the Military Intelligence Section 7 (or MI7 for short) that was
responsible for collecting data from foreign sources, translating it, and transmitting it back to the
allied leadership. Most importantly they maintained strict security.
Our mission is to collect patient data from EHR systems behind firewalls, translate the data to JSON, and securely transmit it
back to our clients. In essence we feel a kinship with MI7, plus we are huge James Bond fans.
Zac joined MI7 as CEO. He is an ex-Innovation Fellow from Department of HHS. Previously he was the CIO of the Louisiana Department of Health and Hospitals amongst other notable healthcare positions.
Randall joined MI7 as COO. He is an ex-Project Leader for the U.S. Olympic Games. Previously he was a President of Tuanis Technology, and a Product Manager at AT&T, amongst other notable operational positions.
Richard joined MI7 as CTO / CHA. He is an ex-Director of Integration for CrunchTime. Previously he was CTO of SubtleData, and CTO of Remote Operations Medical Transcription, amongst other notable technology positions.
Jacob Reider, MD
Jacob joined MI7 as an Advisor. He is an ex-Deputy National Coordinator for the ONC for Health IT at US Department of Health and Human Services. Previously he was the CMIO of Allscripts amongst other notable healthcare positions.
Jordan Shlain, MD
Jordan joined MI7 as an Advisor. He is an ex-Medical Advisor at MD Anderson Cancer Center. Previously he was a Senior Medical Advisor at Optum Global Solutions, amongst other notable healthcare positions.
Steve joined MI7 as an Advisor. He is an ex-Chairman of the Board for the Federal Reserve Bank of Dallas. Previously he was General Partner at Techxas Ventures, and President of Activerse, amongst other notable leadership positions.
Jim joined MI7 as an Advisor and Secretary of the Board. He is an ex-Managing Partner for DLA Piper. Previously he was a Managing Partner of Gray Cary Ware & Freidenrich, and is currently a Partner at DLA Piper.